17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1350676 6480464 Dihydrotestosterone results in increased expression of PHLDB2 mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1558249 6480464 Tetrachlorodibenzodioxin results in decreased expression of PHLDB2 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1558249 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PHLDB2 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1350676 6480464 Tetrachlorodibenzodioxin results in increased expression of PHLDB2 mRNA CTD PMID:20106945 , PMID:21632981 2-hydroxypropanoic acid increases expression ISO RGD:1350676 6480464 Lactic Acid results in increased expression of PHLDB2 mRNA CTD PMID:30851411 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1558249 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of PHLDB2 mRNA CTD PMID:26251327 4,4'-sulfonyldiphenol increases expression ISO RGD:1558249 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PHLDB2 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression ISO RGD:1558249 6480464 Fenretinide results in increased expression of PHLDB2 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of PHLDB2 mRNA CTD PMID:24780913 , PMID:25825206 aflatoxin B1 increases expression ISO RGD:1558249 6480464 Aflatoxin B1 results in increased expression of PHLDB2 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:1350676 6480464 Aflatoxin B1 results in decreased methylation of PHLDB2 gene CTD PMID:27153756 antirheumatic drug increases expression ISO RGD:1350676 6480464 Antirheumatic Agents results in increased expression of PHLDB2 mRNA CTD PMID:24449571 arsenous acid increases expression ISO RGD:1350676 6480464 Arsenic Trioxide results in increased expression of PHLDB2 mRNA CTD PMID:20458559 benzo[a]pyrene decreases expression ISO RGD:1558249 6480464 Benzo(a)pyrene results in decreased expression of PHLDB2 mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO RGD:1350676 6480464 Benzo(a)pyrene affects the methylation of PHLDB2 exon CTD PMID:30157460 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1350676 6480464 7 more ... CTD PMID:19150397 , PMID:20382639 bisphenol A increases expression ISO RGD:1558249 6480464 bisphenol A results in increased expression of PHLDB2 mRNA CTD PMID:26063408 , PMID:30951980 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PHLDB2 mRNA CTD PMID:25181051 bisphenol F increases expression ISO RGD:1558249 6480464 bisphenol F results in increased expression of PHLDB2 mRNA CTD PMID:30951980 butanal decreases expression ISO RGD:1350676 6480464 butyraldehyde results in decreased expression of PHLDB2 mRNA CTD PMID:26079696 cadmium dichloride increases expression ISO RGD:1350676 6480464 Cadmium Chloride results in increased expression of PHLDB2 mRNA CTD PMID:26472689 calcitriol increases expression ISO RGD:1350676 6480464 Calcitriol results in increased expression of PHLDB2 mRNA CTD PMID:16002434 carbamazepine affects expression ISO RGD:1350676 6480464 Carbamazepine affects the expression of PHLDB2 mRNA CTD PMID:25979313 choline multiple interactions ISO RGD:1558249 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PHLDB2 gene CTD PMID:20938992 cisplatin multiple interactions ISO RGD:1350676 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of PHLDB2 mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:1350676 6480464 Cisplatin results in decreased expression of PHLDB2 mRNA CTD PMID:27392435 cobalt dichloride decreases expression ISO RGD:1350676 6480464 cobaltous chloride results in decreased expression of PHLDB2 mRNA CTD PMID:19320972 copper atom multiple interactions ISO RGD:1350676 6480464 [Disulfiram binds to Copper] which results in increased expression of PHLDB2 mRNA CTD PMID:24690739 copper(0) multiple interactions ISO RGD:1350676 6480464 [Disulfiram binds to Copper] which results in increased expression of PHLDB2 mRNA CTD PMID:24690739 copper(II) sulfate decreases expression ISO RGD:1350676 6480464 Copper Sulfate results in decreased expression of PHLDB2 mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:1350676 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 crocidolite asbestos decreases expression ISO RGD:1350676 6480464 Asbestos, Crocidolite results in decreased expression of PHLDB2 mRNA CTD PMID:29523930 cyclosporin A decreases expression ISO RGD:1350676 6480464 Cyclosporine results in decreased expression of PHLDB2 mRNA CTD PMID:20106945 cyclosporin A affects expression ISO RGD:1350676 6480464 Cyclosporine affects the expression of PHLDB2 mRNA CTD PMID:25562108 dexamethasone decreases expression ISO RGD:1558249 6480464 Dexamethasone results in decreased expression of PHLDB2 mRNA CTD PMID:22733784 diarsenic trioxide increases expression ISO RGD:1350676 6480464 Arsenic Trioxide results in increased expression of PHLDB2 mRNA CTD PMID:20458559 dibutyl phthalate increases expression ISO RGD:1558249 6480464 Dibutyl Phthalate results in increased expression of PHLDB2 mRNA CTD PMID:17361019 , PMID:21266533 disulfiram multiple interactions ISO RGD:1350676 6480464 [Disulfiram binds to Copper] which results in increased expression of PHLDB2 mRNA CTD PMID:24690739 diuron decreases expression EXP 6480464 Diuron results in decreased expression of PHLDB2 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:1350676 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDB2 mRNA CTD PMID:27188386 Enterolactone multiple interactions ISO RGD:1350676 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHLDB2 mRNA CTD PMID:19167446 ethyl methanesulfonate decreases expression ISO RGD:1350676 6480464 Ethyl Methanesulfonate results in decreased expression of PHLDB2 mRNA CTD PMID:23649840 fenamidone increases expression ISO RGD:1558249 6480464 fenamidone results in increased expression of PHLDB2 mRNA CTD PMID:27029645 folic acid multiple interactions ISO RGD:1558249 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PHLDB2 gene CTD PMID:20938992 geldanamycin increases expression ISO RGD:1350676 6480464 geldanamycin results in increased expression of PHLDB2 mRNA CTD PMID:26705709 glyphosate decreases methylation EXP 6480464 glyphosate results in decreased methylation of PHLDB2 gene CTD PMID:31011160 hexadecanoic acid decreases phosphorylation ISO RGD:1350676 6480464 Palmitic Acid results in decreased phosphorylation of PHLDB2 protein CTD PMID:28073184 isobutanol multiple interactions ISO RGD:1350676 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased chemical synthesis of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PHLDB2 mRNA CTD PMID:29432896 L-methionine multiple interactions ISO RGD:1558249 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PHLDB2 gene CTD PMID:20938992 melphalan decreases expression ISO RGD:1350676 6480464 Melphalan results in decreased expression of PHLDB2 mRNA CTD PMID:22363485 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of PHLDB2 mRNA CTD PMID:24136188 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of PHLDB2 mRNA CTD PMID:24136188 ochratoxin A decreases expression ISO RGD:1350676 6480464 ochratoxin A results in decreased expression of PHLDB2 mRNA CTD PMID:30559759 paracetamol affects expression ISO RGD:1558249 6480464 Acetaminophen affects the expression of PHLDB2 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:1350676 6480464 Acetaminophen results in decreased expression of PHLDB2 mRNA CTD PMID:21420995 phenobarbital affects expression ISO RGD:1558249 6480464 Phenobarbital affects the expression of PHLDB2 mRNA CTD PMID:23091169 pirinixic acid decreases expression ISO RGD:1558249 6480464 pirinixic acid results in decreased expression of PHLDB2 mRNA CTD PMID:18445702 quercetin decreases expression ISO RGD:1350676 6480464 Quercetin results in decreased expression of PHLDB2 mRNA CTD PMID:21632981 rac-lactic acid increases expression ISO RGD:1350676 6480464 Lactic Acid results in increased expression of PHLDB2 mRNA CTD PMID:30851411 resveratrol multiple interactions ISO RGD:1350676 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of PHLDB2 mRNA CTD PMID:19167446 rotenone increases expression EXP 6480464 Rotenone results in increased expression of PHLDB2 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:1350676 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDB2 mRNA CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1350676 6480464 Silicon Dioxide analog results in increased expression of PHLDB2 mRNA CTD PMID:25895662 silver atom increases expression ISO RGD:1350676 6480464 Silver results in increased expression of PHLDB2 mRNA CTD PMID:28959546 silver atom decreases expression ISO RGD:1350676 6480464 Silver results in decreased expression of PHLDB2 mRNA CTD PMID:26551752 silver(0) increases expression ISO RGD:1350676 6480464 Silver results in increased expression of PHLDB2 mRNA CTD PMID:28959546 silver(0) decreases expression ISO RGD:1350676 6480464 Silver results in decreased expression of PHLDB2 mRNA CTD PMID:26551752 sodium arsenite decreases expression ISO RGD:1350676 6480464 sodium arsenite results in decreased expression of PHLDB2 mRNA CTD PMID:12679051 sunitinib decreases expression ISO RGD:1350676 6480464 Sunitinib results in decreased expression of PHLDB2 mRNA CTD PMID:31533062 tetrachloromethane affects expression ISO RGD:1558249 6480464 Carbon Tetrachloride affects the expression of PHLDB2 mRNA CTD PMID:17484886 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of PHLDB2 mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO RGD:1558249 6480464 Carbon Tetrachloride results in increased expression of PHLDB2 mRNA CTD PMID:27339419 thimerosal decreases expression ISO RGD:1350676 6480464 Thimerosal results in decreased expression of PHLDB2 mRNA CTD PMID:27188386 titanium dioxide affects expression ISO RGD:1558249 6480464 titanium dioxide affects the expression of PHLDB2 mRNA CTD PMID:23557971 trichostatin A increases expression ISO RGD:1350676 6480464 trichostatin A results in increased expression of PHLDB2 mRNA CTD PMID:24935251 triclosan increases expression ISO RGD:1350676 6480464 Triclosan results in increased expression of PHLDB2 mRNA CTD PMID:30510588 troglitazone decreases expression ISO RGD:1350676 6480464 troglitazone results in decreased expression of PHLDB2 mRNA CTD PMID:25572481 urethane decreases expression ISO RGD:1350676 6480464 Urethane results in decreased expression of PHLDB2 mRNA CTD PMID:28818685 valproic acid decreases methylation ISO RGD:1350676 6480464 Valproic Acid results in decreased methylation of PHLDB2 gene CTD PMID:29154799 valproic acid affects expression ISO RGD:1350676 6480464 Valproic Acid affects the expression of PHLDB2 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1350676 6480464 Valproic Acid results in increased expression of PHLDB2 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1350676 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDB2 mRNA CTD PMID:27188386 vorinostat affects expression ISO RGD:1350676 6480464 vorinostat affects the expression of PHLDB2 mRNA CTD PMID:27188386 
Gene-Chemical Interaction Annotations
